[HTML][HTML] Role and therapeutic targeting of the PI3K/Akt/mTOR signaling pathway in skin cancer: a review of current status and future trends on natural and synthetic …

JC Chamcheu, T Roy, MB Uddin, S Banang-Mbeumi… - Cells, 2019 - mdpi.com
The mammalian or mechanistic target of rapamycin (mTOR) and associated phosphatidyl-
inositiol 3-kinase (PI3K)/protein kinase B (Akt) pathways regulate cell growth, differentiation …

[HTML][HTML] The PI3K/Akt pathway: emerging roles in skin homeostasis and a group of non-malignant skin disorders

Y Teng, Y Fan, J Ma, W Lu, N Liu, Y Chen, W Pan… - Cells, 2021 - mdpi.com
The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway regulates
cell proliferation, differentiation, and migration, along with angiogenesis and metabolism …

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

L Yu, J Wei, P Liu - Seminars in cancer biology, 2022 - Elsevier
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …

[HTML][HTML] Recent updates on the involvement of PI3K/AKT/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders

L Mercurio, C Albanesi, S Madonna - Frontiers in medicine, 2021 - frontiersin.org
PhosphoInositide-3 Kinase (PI3K) represents a family of different classes of kinases which
control multiple biological processes in mammalian cells, such as cell growth, proliferation …

[HTML][HTML] The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy …

T Roy, ST Boateng, MB Uddin, S Banang-Mbeumi… - Cells, 2023 - mdpi.com
The dysregulated phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin
(mTOR) signaling pathway has been implicated in various immune-mediated inflammatory …

[HTML][HTML] PI3K/Akt/mTOR pathway and its role in cancer therapeutics: are we making headway?

Y Peng, Y Wang, C Zhou, W Mei, C Zeng - Frontiers in oncology, 2022 - frontiersin.org
Cancer is a severe public health issue that is a leading cause of mortality globally. It is also
an impediment to improving life expectancy worldwide. Furthermore, the global burden of …

PI3K and mTOR signaling pathways in cancer: new data on targeted therapies

L Willems, J Tamburini, N Chapuis, C Lacombe… - Current oncology …, 2012 - Springer
The mammalian target of rapamycin (mTOR) and the phosphoinositide 3-kinase (PI3K)
signaling pathways are commonly deregulated in cancers and promote cellular growth …

[HTML][HTML] Predominant role of mTOR signaling in skin diseases with therapeutic potential

F Karagianni, A Pavlidis, LS Malakou, C Piperi… - International Journal of …, 2022 - mdpi.com
The serine/threonine kinase mechanistic target of rapamycin (mTOR) plays a pivotal role in
the regulation of cell proliferation, survival, and motility in response to availability of energy …

Targeting PI3 kinase in cancer

TM Bauer, MR Patel, JR Infante - Pharmacology & therapeutics, 2015 - Elsevier
Abstract The PI3K/Akt/mTOR pathway is the most frequently known activated aberrant
pathway in human cancers. Pathologic activation can occur at multiple levels along the …

Targeting PI3 kinase/AKT/mTOR signaling in cancer

K Sheppard, KM Kinross, B Solomon… - Critical Reviews™ in …, 2012 - dl.begellhouse.com
The phosphatidylinositol 3 kinase (PI3K) pathway is one of the major pathways modulating
cell growth, proliferation, metabolism, survival, and angiogenesis. Hyperactivation of this …